Expanding our knowledge
of cell therapy manufacturing
OUR CAPABILITIES
Reliable partner for cell & gene therapy manufacturing
As a long-term manufacturing partner, we will strategically guide our business partners through every step of the cell therapy manufacturing chain. We offer full services covering GMP production of Advanced Therapy Medicinal Products including genetically modified and viral vectors. SCTbio leverages a decade of experience
in development of autologous cell-based products, product supply for clinical trials, GMP compliance for the full lifecycle of drug development, manufacturing, quality control, QA/QP release, storage and logistics services and process development services to deliver the highest quality collaboration for your CDMO needs.
History of SCTbio
SCTbio was formed on July 1, 2021, and is a part of PPF Biotech network. The key company and personnel capabilities have been generated within SOTIO Group, during its more than 10 years of history of drug development and manufacturing. All of SOTIO’s cell and gene therapy GMP manufacturing capabilities have been outsourced to SCTbio, including our GMP manufacturing facility in Prague, Czech Republic.
12 years
in cell and gene therapy field
2.000 sqm
facility area including 420sqm of GMP clean rooms
80+
reliable team members
Our Team
Luděk Sojka
Chief Executive Officer
Pascale Charbonnel
Chief Business Officer
[email protected]
Klára Murcková
Production Manager
Daniela Rožková
Chief Technology Officer
Martin Pávek
Chief Operating Officer
Jakub Čierný
Chief Quality Compliance Officer
Cell & Gene on the Med
April 15 - 17, 2025, Roma
German Biotech Days
April 9 - April 10, 2025, Heidelberg Congress Center, Berlin
Advanced Therapies Congress, London
March 18-19, 2025 at ExCel, London
SCTbio Brochure
SCTbio Your Reliable Partner for Cell & Gene Therapy GMP Manufacturing
SCTbio Brochure for Analytical Services
Check-out SCTbio full range of analytical capabilities!
SCTbio and Cyto-care Collaborate to Improve Cell Therapy Cryopreservation and Logistics Capabilities in Europe
Source: Press Release - Prague, Czech Republic and Vienna, Austria
Orgenesis Announces Collaboration Agreement with SCTbio for the Production of Lentivirus Vectors
Source: Press Release - Germantown, MD and Prague, Czech Republic
SCTbio Video
Take a tour of our GMP manufacturing facility in Prague.
Ukázka článku - Media
Praesent nec arcu lorem. Nulla vitae malesuada nisl, nec laoreet enim. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
“SCTbio already had an impressive track record of experience with autologous cell therapy manufacturing, including not just GMP manufacturing and analytical capabilities, but a sophisticated cold chain operation, scheduling and supply chain software, and extensive network of qualified leukapheresis sites.”
“Auditing SCTbio revealed to us a company in which GMP culture is deeply rooted, the quality system is well structured, and GMP readiness is not just a marketing keyword thanks to the constant effort of SCTbio’s people, their expertise, their commitment, and their attention to quality.”
